Daptomycin for Injection — Class I drug recall D-1484-2020
Terminated recall by Mylan Institutional LLC, reported 2020-08-12, distributed nationwide. Presence of Particulate Matter
| Recall number | D-1484-2020 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mylan Institutional LLC, Rockford, IL, United States |
| Recall initiated | 2020-07-07 |
| Classified | 2020-08-04 |
| Reported by FDA | 2020-08-12 |
| Terminated | 2023-01-27 |
| Distributed | Nationwide (US) |
| Quantity | 18,480 vials |
| Reason classes | specification failure |
| NDC | 67457-0813, 67457-0813-50 |
| Lot numbers | 7605112 |
| Expiration dates | 2021-10 |
Product
Daptomycin for Injection, 500 mg/vial, Single-Dose Vial, Rx only, Sterile, Manufactured for: Mylan Institutional, LLC, Rockford, IL 61103 USA, NDC 67457-813-50
Reason for recall
Presence of Particulate Matter
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1484-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.